Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure I: Introduction

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

Heart Failure III: Clinical Manifestations

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...

Heart Failure VII: Nursing Interventions

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical suspicion, diagnosis and management of cardiac amyloidosis: update document and executive summary.

Revista clinica espanola·2024

Same author

Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with thiazide diuretics for decompensated heart failure) trial.

Revista clinica espanola·2024

Same author

Consensus on improving the comprehensive care of patients with acute heart failure.

Revista clinica espanola·2023

Same author

Assessment of frailty in the person with type 2 diabetes mellitus: Expert analysis.

Revista clinica espanola·2023

Same author

Executive summary of the 2023 update on the consensus regarding basic conduct during hospital admission for patients with acute heart failure.

Revista clinica espanola·2023

Same author

Type 2 diabetes mellitus in elderly or frail individuals. Topics to be considerer.

Revista clinica espanola·2022

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

[Anemia in chronic heart failure].

J Grau-Amorós¹, F Formiga, A Urrutia

¹Servicio de Medicina Interna, Hospital Municipal de Badalona, Barcelona, España. jgrau@bsa.cat

Revista Clinica Espanola

|May 31, 2011

Summary

Anemia is a common comorbidity in chronic heart failure patients. Current guidelines lack specific treatment recommendations, despite evidence of improved outcomes with anemia management.

Area of Science:

Internal Medicine
Cardiology
Geriatrics

Context:

Anemia frequently co-occurs with decompensated chronic heart failure (CHF) in hospitalized patients.
Despite evidence supporting anemia treatment for improved functional capacity and reduced readmissions, clinical practice guidelines offer no specific directives.
This clinical challenge is ideal for internists due to its multifactorial nature, involving heart failure, anemia, and other geriatric syndromes.

Purpose:

To highlight the gap in clinical practice guidelines regarding anemia management in decompensated chronic heart failure.
To emphasize the need for a comprehensive approach by internists to address the complex interplay of comorbidities in these patients.

Summary:

Anemia is a prevalent comorbidity in decompensated chronic heart failure (CHF) patients.

Related Experiment Videos

Last Updated: Jun 1, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Evidence supports anemia treatment to enhance patient function and decrease hospital readmissions.

Clinical guidelines currently lack specific recommendations for managing anemia in this population.

Impact:

Addressing anemia in CHF patients can improve their functional capacity and reduce hospital readmission rates.
Highlights the need for updated clinical guidelines to incorporate evidence-based anemia management strategies for heart failure patients.
Emphasizes the internist's role in managing complex, multifactorial conditions like anemia and heart failure concurrently.